![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
GEODE-II: Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Patients With Genotype 1a Chronic Hepatitis C Virus Infection Without Cirrhosis
|
|
|
Reported by Jules Levin
EASL Special Conference, New Perspectives in Hepatitis C Virus Infection- Roadmap for the Cure, 23-24 September 2016, in Paris, France
Fred Poordad1, Shahriar Sedghi2, Paul J Pockros3, Natarajan Ravendhran4, Robert Reindollar5, Michael R Lucey6, Michael Epstein7, Leslie Bank8, David Bernstein9, Roger Trinh10, Preethi Krishnan10, Tami Pilot-Matias10, Akshanth R Polepally10, Rajvineeth Kumar Pothacamury10, Kristina Unnebrink12, Marisol Martinez10, David R Nelson11 1Texas Liver Institute, University of Texas Health Science Center, San Antonio, Texas, United States; 2Associate Professor of Medicine and Surgery, Mercer University School of Medicine, Macon, Georgia, United States; 3Division of Gastroenterology/Hepatology, Scripps Clinic, La Jolla, California, United States; 4Digestive Disease Associates, Baltimore, Maryland, United States; 5Piedmont Healthcare/Carolinas Center for Liver Disease, Statesville, North Carolina, United States; 6Division of Gastroenterology/Hepatology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States; 7Anne Arundel Medical Center, Digestive Disorders Associates, Annapolis, Maryland, United States; 8Principal Investigator, Regional Clinical Research Inc., Endwell, New York, United States; 9Hofstra Northwell School of Medicine, Manhasset, New York, United States; 10AbbVie Inc., North Chicago, Illinois, United States; 11Department of Medicine, University of Florida, Gainesville, Florida, United States; 12AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany
![IAC1](../images/092616/092616-6/IAC1.gif)
![IAC22](../images/092616/092616-6/IAC22.gif)
![KeyEl](../images/092616/092616-6/KeyEl.gif)
![IAC4](../images/092616/092616-6/IAC4.gif)
![IAC5](../images/092616/092616-6/IAC5.gif)
![IAC6](../images/092616/092616-6/IAC6.gif)
![IAC6](../images/092616/092616-6/IAC6.gif)
![IAC7](../images/092616/092616-6/IAC7.gif)
![IAC8](../images/092616/092616-6/IAC8.gif)
![IAC9](../images/092616/092616-6/IAC9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|